|
|
|
| Webinar: Critical Imaging Risks in GLP-1 and Neurology Studies: What You Need to Know | Clinical trials in GLP-1 and neurology rely increasingly on imaging, but challenges often go unaddressed. This webinar covers early indicators of imaging issues, preclinical insights, expanding imaging requirements, and hidden risks. Attendees will learn how early identification of imaging risks, preclinical data, and strategic planning can mitigate delays, improve trial efficiency, and ensure regulatory compliance. Click here to learn more. |
|
|
|
|
By Christopher Ohms, Ohms Consulting | The U.S. pharma industry has relied heavily on China and India to produce regulatory starting materials and APIs. The BIOSECURE Act has now emerged. Is this the first real step toward reshoring? | |
|
|
| "Bestcellers": Controlled Filling And Freezing Of Cells | Application Note | Single Use Support | Learn how state-of-the-art technologies provide control over the freeze-thaw process fostering drug discovery and development, thus facilitating commercial production of novel treatments. |
|
|
|
|
|
|
By Booma Yandava, MS, MBA | This article details why iPSC-based therapies offer promising yet experimental solutions for neurological disorders with early clinical studies demonstrating safety and potential efficacy, though long-term outcomes remain to be validated. | |
|
|
|
|
|
|
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
